title: Angelman syndrome: correlations between epilepsy phenotypes and genotypes.
abstract: We compared epilepsy phenotypes with genotypes of Angelman syndrome (AS), including chromosome 15q11-13 deletions (class I), uniparental disomy (class II), methylation imprinting abnormalities (class III), and mutation in the UBE3A gene (class IV). Twenty patients were prospectively selected based on clinical cytogenetic and molecular diagnosis of AS. All patients had 6 to 72 hours of closed-circuit television videotaping and digitized electroencephalogrpahic (EEG) telemetry. Patients from all genotypic classes had characteristic EEGs with diffuse bifrontally dominant high-amplitude 1- to 3-Hz notched or triphasic or polyphasic slow waves, or slow and sharp waves. Class I patients had severe intractable epilepsy, most frequently with atypical absences and myoclonias and less frequently with generalized extensor tonic seizures or flexor spasms. Epileptic spasms were recorded in AS patients as old as 41 years. Aged-matched class II, III, and IV patients had either no epilepsy or drug-responsive mild epilepsy with relatively infrequent atypical absences, myoclonias, or atonic seizures. In conclusion, maternally inherited chromosome 15q11-13 deletions produce severe epilepsy. Loss-of-function UBE3A mutations, uniparental disomy, or methylation imprint abnormalities in AS are associated with relatively mild epilepsy. Involvement of other genes in the chromosome 15q11-13 deletion, such as GABRB3, may explain severe epilepsy in AS.
authors.affiliation: Department of Neurology, University of California, Los Angeles, School of Medicine, and West Los Angeles DVA Medical Center, 90073, USA.
authors.forename: B A
authors.initials: BA
authors.lastname: Minassian
authors.forename: T M
authors.initials: TM
authors.lastname: DeLorey
authors.forename: R W
authors.initials: RW
authors.lastname: Olsen
authors.forename: M
authors.initials: M
authors.lastname: Philippart
authors.forename: Y
authors.initials: Y
authors.lastname: Bronstein
authors.forename: Q
authors.initials: Q
authors.lastname: Zhang
authors.forename: R
authors.initials: R
authors.lastname: Guerrini
authors.forename: P
authors.initials: P
authors.lastname: Van Ness
authors.forename: M O
authors.initials: MO
authors.lastname: Livet
authors.forename: A V
authors.initials: AV
authors.lastname: Delgado-Escueta
mesh_terms: D000293:Adolescent; D000328:Adult; D000367:Age Factors; D017204:Angelman Syndrome / Q000235:genetics* / Q000503:physiopathology; D002648:Child; D002675:Child, Preschool; D002869:Chromosome Aberrations; D002872:Chromosome Deletion; D025063:Chromosome Disorders; D002874:Chromosome Mapping; D002884:Chromosomes, Human, Pair 15; D019175:DNA Methylation; D004569:Electroencephalography; D004827:Epilepsy / Q000235:genetics* / Q000503:physiopathology; D005260:Female; D018392:Genomic Imprinting; D005838:Genotype; D006801:Humans; D008025:Ligases / Q000235:genetics; D008297:Male; D010641:Phenotype; D012640:Seizures / Q000235:genetics / Q000503:physiopathology; D044767:Ubiquitin-Protein Ligases
chemical_list: C471639:UBE3A protein, human; D044767:Ubiquitin-Protein Ligases; D008025:Ligases